MAA
BPMC

Managed Account Advisors’s Blueprint Medicines BPMC Stock Holding History

Managed Account Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$4K Buy
+153
New +$4.37K ﹤0.01% 2949

Other funds holding BPMC

TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Managed Account Advisors's BPMC Position: Q2 2015 in Review

Managed Account Advisors opened a new position in Blueprint Medicines (BPMC) in Q2 2015: 153 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #2949 among its holdings.

70 funds tracked by Wall St. Rank hold BPMC as of Q2 2015.

  • Managed Account Advisors held 153 shares of Blueprint Medicines worth $4K as of Q2 2015.
  • Blueprint Medicines was a new Managed Account Advisors position in Q2 2015.
  • Blueprint Medicines made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2949 holding.
  • 70 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.